Ciprofloxacin study warns of adverse events

Ciprofloxacin (Cipro), the medicine of choice for treatingcutaneous anthrax as well as other forms of the disease, can cause adversedrug reactions in both the central nervous system and the peripheral nervoussystem, according to studies in The Journal of Pharmacotherapy

Related Videos
Related Content

Frontline Forum Part 4: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

March 30th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Silybum Marianum Fruit Extract Safe, Effective in Acne-Prone Skin

March 29th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

EON Gains FDA Clearance for Back and Thighs

March 29th 2023

Botulinum Toxin Type A Unparallel Improvements to Skin Quality

March 29th 2023

Frontline Forum Part 4: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

March 30th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Silybum Marianum Fruit Extract Safe, Effective in Acne-Prone Skin

March 29th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

EON Gains FDA Clearance for Back and Thighs

March 29th 2023

Botulinum Toxin Type A Unparallel Improvements to Skin Quality

March 29th 2023

Frontline Forum Part 4: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies

March 30th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Silybum Marianum Fruit Extract Safe, Effective in Acne-Prone Skin

March 29th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

EON Gains FDA Clearance for Back and Thighs

March 29th 2023

Botulinum Toxin Type A Unparallel Improvements to Skin Quality

March 29th 2023
© 2023 MJH Life Sciences

All rights reserved.